Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less
NQ Score
50/100
AI Summary (NQ-processed)
At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the primary material used in IPCL lenses?
- A: It uses an acrylic polymer material primarily composed of HEMA.
- Q: When did IPCL receive approval from the Ministry of Health, Labour and Welfare in Japan?
- A: It obtained regulatory approval from the Ministry of Health, Labour and Welfare in April 2025.
- Q: Why is IPCL considered a highly reversible treatment compared to LASIK?
- A: Unlike LASIK, it does not involve shaving the cornea, making it possible to remove the lens in the future.
- Q: Who was the target group for the survey conducted by Working Co., Ltd.?
- A: The survey targeted nationwide men and women in their 20s to 40s who have a vision of 0.1 or less.
- Q: What percentage of the survey subjects were interested in the implantable contact lens treatment method?
- A: About 70% (71.9%) of the survey subjects were interested in it as a treatment method.